Novo Holdings A/S’s VectivBio Holding AG Ordinary Shares VECT Stock Holding History

Novo Holdings A/S’s Portfolio VECT Stock Details VECT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,610,461	Closed	-$30.7M	–	47
2023 Q1	$30.7M	Buy	3,610,461 +270,977	+8%	+$2.23M	2.03%	17
2022 Q4	$28.9M	Hold	3,339,484	–	–	1.81%	19
2022 Q3	$20M	Hold	3,339,484	–	–	0.96%	21
2022 Q2	$18M	Sell	3,339,484 -40,918	-1%	-$220K	0.89%	20
2022 Q1	$15.9M	Sell	3,380,402 -141,617	-4%	-$740K	0.84%	23
2021 Q4	$17.3M	Hold	3,522,019	–	–	0.82%	24
2021 Q3	$27.2M	Hold	3,522,019	–	–	1.41%	16
2021 Q2	$41.1M	Buy	+3,522,019	New	+$53.5M	1.82%	16

Other funds holding VECT

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Novo Holdings A/S's VECT Position: Q2 2023 in Review

Novo Holdings A/S sold out of VectivBio Holding AG Ordinary Shares (VECT) in Q2 2023, closing a stake of 3,610,461 shares — an estimated $30.7M sold.

Novo Holdings A/S first reported a position in VECT in Q2 2021 and held it in 8 quarters. The position peaked at $41.1M in Q2 2021. 49 funds tracked by Wall St. Rank hold VECT as of Q2 2023.

Novo Holdings A/S reported no remaining VectivBio Holding AG Ordinary Shares position as of Q2 2023 after selling out during the quarter.
Novo Holdings A/S sold 3,610,461 VectivBio Holding AG Ordinary Shares shares in Q2 2023, an estimated $30.7M.
Novo Holdings A/S first reported a position in VectivBio Holding AG Ordinary Shares in Q2 2021 and held it in 8 quarters.
Novo Holdings A/S's VectivBio Holding AG Ordinary Shares position peaked at $41.1M in Q2 2021.
49 funds tracked by Wall St. Rank held VectivBio Holding AG Ordinary Shares as of Q2 2023.

Based on Novo Holdings A/S's 13F filing for Q2 2023, filed 14 Aug 2023.